The SofPulse device is a wearable that uses targeted pulsed electromagnetic field technology to reduce swelling and speed up natural recovery processes, reducing the need for pain medication, according to its website.
“Endonovo’s public awareness campaign will focus on educating hospitals and MDs regarding SofPulse’s proven ability to reduce pain and edema post-operatively while significantly reducing costs associated with surgeries,” Alan Collier, Endonovo CEO, said in a statement.
Read the full release here.
More articles on surgery centers:
CRH, physicians open anesthesia practice
New guidelines to reduce post-surgery opioid prescriptions miss subset of patients, researchers say
Collegium, Teva reach settlement over extended-release oxycodone patent
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
